Review
Copyright ©The Author(s) 2015.
World J Diabetes. Apr 15, 2015; 6(3): 380-390
Published online Apr 15, 2015. doi: 10.4239/wjd.v6.i3.380
Figure 3
Figure 3 The measurement of serum islet autoantibodies has made type 1 diabetes a predictable disease. Early identification of islet autoantibody positive individuals leads to improved clinical outcomes by decreasing the risk for diabetic ketoacidosis and potentially preserving beta cell mass through clinical prevention trials. T1D: Type 1 diabetes; INIT-II: Intranasal Insulin Trial.